Alexander colevas
Alexander colevas
Profewssor of Medicine, Stanford University
Verified email at stanford.edu - Homepage
Title
Cited by
Cited by
Year
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
N Engl J Med 375, 1856-1867, 2016
28262016
CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti, AD Colevas, A Setser, V Rusch, D Jaques, V Budach, C Langer, ...
Seminars in radiation oncology 13 (3), 176-181, 2003
27602003
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ...
New England Journal of Medicine 357 (17), 1705-1715, 2007
17852007
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...
The Lancet 393 (10166), 40-50, 2019
5612019
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia
JC Byrd, TS Lin, JT Dalton, D Wu, MA Phelps, B Fischer, M Moran, ...
Blood 109 (2), 399-404, 2007
4392007
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by …
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
Oral oncology 81, 45-51, 2018
3562018
A phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
LB Nabors, T Mikkelsen, S Rosenfeld, F Hochberg, NS Akella, JD Fisher, ...
Journal of clinical oncology: official journal of the American Society of …, 2007
3492007
E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of …
S Marur, S Li, AJ Cmelak, ML Gillison, WJ Zhao, RL Ferris, WH Westra, ...
Journal of Clinical Oncology 35 (5), 490, 2017
3142017
NCCN guidelines insights: head and neck cancers, version 1.2018
AD Colevas, SS Yom, DG Pfister, S Spencer, D Adelstein, D Adkins, ...
Journal of the National Comprehensive Cancer Network 16 (5), 479-490, 2018
3112018
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
NY Lee, Q Zhang, DG Pfister, J Kim, AS Garden, J Mechalakos, K Hu, ...
The lancet oncology 13 (2), 172-180, 2012
3022012
Patient-reported outcomes and the evolution of adverse event reporting in oncology
A Trotti, AD Colevas, A Setser, E Basch
Journal of Clinical Oncology 25 (32), 5121-5127, 2007
2912007
Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
JM Albert, C Cao, KW Kim, CD Willey, L Geng, D Xiao, H Wang, A Sandler, ...
Clinical cancer research 13 (10), 3033-3042, 2007
2912007
Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck
AD Colevas
Journal of Clinical Oncology 24 (17), 2644-2652, 2006
2822006
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related …
KJ Harrington, RL Ferris, G Blumenschein Jr, AD Colevas, J Fayette, ...
The Lancet Oncology 18 (8), 1104-1115, 2017
2622017
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
HE Kohrt, R Houot, K Weiskopf, MJ Goldstein, F Scheeren, D Czerwinski, ...
The Journal of clinical investigation 122 (3), 1066-1075, 2012
2522012
NCCN guidelines insights: head and neck cancers, version 2.2017
D Adelstein, ML Gillison, DG Pfister, S Spencer, D Adkins, DM Brizel, ...
Journal of the National Comprehensive Cancer Network 15 (6), 761-770, 2017
2382017
Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study
R Haddad, AD Colevas, JF Krane, D Cooper, B Glisson, PC Amrein, ...
Oral oncology 39 (7), 724-727, 2003
2282003
Head and neck cancers, version 2.2014
DG Pfister, S Spencer, DM Brizel, B Burtness, PM Busse, JJ Caudell, ...
Journal of the National Comprehensive Cancer Network 12 (10), 1454-1487, 2014
2272014
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate …
MD Galsky, EJ Small, WK Oh, I Chen, DC Smith, AD Colevas, L Martone, ...
Journal of Clinical Oncology 23 (7), 1439-1446, 2005
2162005
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck
MR Posner, B Glisson, G Frenette, M Al-Sarraf, AD Colevas, CM Norris, ...
Journal of clinical oncology 19 (4), 1096-1104, 2001
2072001
The system can't perform the operation now. Try again later.
Articles 1–20